Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3999361 | Urologic Oncology: Seminars and Original Investigations | 2016 | 12 Pages |
Abstract
Our findings provide insight into the specific RNAa of miR-1236-targeted p21 promoter activation in suppressing RCC cell proliferation. Considering the poor prognostic outcomes associated with reduced miR-1236 and p21 expression, our data imply that these factors likely play important antitumor effects in RCC progression.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Chenghe M.D., Ph.D., Kun M.D., Ph.D., Zhen Ph.D., Zhong M.D., Ph.D., Hua Ph.D., Zhangqun M.D., Ph.D.,